Prosecution Insights
Last updated: April 19, 2026

Examiner: KUCHARCZK, JED A

Tech Center 1600 • Art Units: 1623 1626

This examiner grants 80% of resolved cases

Performance Statistics

80.0%
Allow Rate
+20.0% vs TC avg
117
Total Applications
+20.9%
Interview Lift
949
Avg Prosecution Days
Based on 85 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
17.0%
§102 Novelty
31.6%
§103 Obviousness
27.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17996310 HERBICIDAL COMPOUNDS Non-Final OA SYNGENTA CROP PROTECTION AG
17721813 COMPOSITIONS AND THEIR USE Non-Final OA SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
19220457 METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS Non-Final OA Otsuka Pharmaceutical Co., Ltd.
17311624 COMPOSITIONS AND METHODS FOR REGULATING INFLAMMATION Final Rejection University of Virginia Patent Foundation
18258346 NOVEL NAMPT ENZYME AGONIST AND PREPARATION AND USE THEREOF Non-Final OA TSINGHUA UNIVERSITY
18020451 Serotonin Receptor Modulators Final Rejection Northeastern University
17628106 Modulators of Excitatory Amino Acid Transporters and Methods Using Same Final Rejection Drexel University
17829917 METHODS OF INCREASING CELL PHAGOCYTOSIS Final Rejection Academia Sinica
18574939 CANNABICHROMENE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME Non-Final OA University of Mississippi
18099319 ORAL CAPSULE AND PREPARATION METHOD THEREFOR Final Rejection BEIGENE SWITZERLAND GMBH
17617531 ORAL CAPSULE AND PREPARATION METHOD THEREFOR Final Rejection BEIGENE SWITZERLAND GMBH
16980773 PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO Non-Final OA Cerecin Inc.
17620427 FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE Non-Final OA Belite Bio, LLC
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES Non-Final OA JAPAN SCIENCE AND TECHNOLOGY AGENCY
18249647 ORAL CANNABINOID FORMULATION COMPRISING MEDIUM CHAIN TRIGLYCERIDES AND TOCOPHERYL PHOSPHATES Non-Final OA AVECHO BIOTECHNOLOGY LIMITED
18030846 CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF Non-Final OA UNIVERZITA PALACKEHO V OLOMOUCI
17281210 SYNERGISTIC PESTICIDAL COMPOSITIONS FOR DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS THEREFOR Non-Final OA 0903608 B.C. Ltd.
17764922 MEDICINAL COGNITIVE TREATMENTS Non-Final OA ACTINOGEN MEDICAL LIMITED
17633150 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES Final Rejection Aclipse One Inc.
17258112 COMPOSITION CONTAINING A 7BETA-HYDROXYCHOLESTEROL AND A LIPID VEHICLE, AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES Non-Final OA BETA INNOV

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month